Previous 10 | Next 10 |
home / stock / cl / cl articles
New Cannabis CEOs, CFOs And Other Appointments Canadian medical cannabis giant Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) announced on Tuesday tha...
As of Jan. 30, 2024, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria...
Raymond James analyst Olivia Tong upgraded Colgate-Palmolive Co (NYSE:CL) to Outperform from Market Perform and announced a $91...
With both chambers of the Ohio legislature scheduled to have one more session each before taking a month off in March, the question of coming up wi...
The CNN Money Fear and Greed index showed a slight decline in the overall market sentiment, but the index remained in the "Extreme Greed"...
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling over 50 points on Friday The Dow traded up 0.05% to 38,069.66...
Colgate-Palmolive Company (NYSE:CL) reported fourth-quarter FY23 sales growth of 7% year-on-year to $4.95 billion, beating the analyst co...
After barely holding up so far this week, market sentiment seems to have taken a downturn in the final trading session. Negative reactions to earni...
With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: Wall Street exp...
News, Short Squeeze, Breakout and More Instantly...
Colgate-Palmolive Company Company Name:
CL Stock Symbol:
NYSE Market:
Colgate-Palmolive Company Website:
Shares of Colgate-Palmolive Company (NYSE: CL) traded at a new 52-week high today and are currently trading at $100.31. So far today, approximately 1.09M shares have been exchanged, as compared to an average 30-day volume of 3.69M shares. Colgate-Palmolive Company, together with its subsidiar...
2024-07-26 15:15:03 ET HSBC analyst issues HOLD recommendation for CL on July 26, 2024 01:54PM ET. CL was trading at $99.51 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 12 - Buy, 5 - Hold recommendatio...
Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...